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In The Notebooks o f Malte Laurids Brigge, the “heavy, difficult book” 
begun in Rome during the winter of 1903-4 and not finished until 
1910 in Paris, Rilke employs a series of rapid, jolting impressions to 
express his pervasive concern with death and his distress about the 
institutional character of death among the poor. To convey an image 
of poverty, he describes the worn furniture of a cheap rented room: 
“if I were not poor I would rent another room with furniture not so 
worn out, not so full of former occupants, as the furniture here. At 
first it really cost me an effort to lean my head on this arm-chair; for 
there is a certain greasy-grey hollow in its green covering, into wTiich 
all heads seem to fit.”1 To portray the nature of dying in medical 
institutions for the poor, he describes the Hotel-Dieu, the hospital 
for the poor, across the plaza from the Cathedral of Paris: “This 
excellent hotel is very ancient. Even in King Clovis’ time people died 
in it in a number of beds. Now they are dying there in 559 beds. 
Factory-like, of course. Where production is so enormous an individ­
ual death is not so nicely carried out; but then that doesn’t matter. It 
is quantity that counts.”2 And to describe the actual medical course of 
dying among the poor and sometimes even the rich, he creates the 
notion of what might be called the “official” death for a given disease, 
that is, its standard or most likely outcome: “the wish to have a death 
of one’s own is growing ever ra re r.. . .  One dies just as it comes; one 
dies the death that belongs to the disease one has, for since one has 
come to know all diseases, one knows, too, that the different lethal
*For their comments, I would like to thank Larry Brown, Paul Menzel, Dan Brock, 
Allen Buchanan, and participants in the Seventh Utah Conference on Ethics and Health, 
January 17-18, 1991, where an earlier version of this essay was originally presented.
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te rm inations belong to  the diseases and n o t to the  people; and the 
sick person  has so to  speak no th ing  to d o .”3
In this short essay I’d like to take Rilke’s ra th e r  enigm atic, 
im pressionist descrip tions seriously, n o t ju s t to discover what it is 
th a t d isturbs h im  abou t the m edical ch arac ter o f dying am ong the 
tu rn-o f-the-cen tury  E uropean  poor, b u t to see what this ex traord i­
nary p o e t’s in tu itions m ight tell us about tu rn-of-the-next-century  
n ational health  care. W hat troubles Rilke m ost, I think, is what we 
m ight call the p rospect o f standardization: the tendency o f a system to 
trea t people u n d e r its con tro l in  a uniform , regulated, unind iv idual­
ized way—robbing  them , Rilke hints, o f the  capacity to func tion  fully 
as persons. T he p o o r are the  im m ediate victims, since they are 
econom ically powerless to resist; b u t even the  rich  can be co-opted  by 
expectations in m edicine which have the  same standardizing and 
hence dehum anizing effect.
T he p rospect o f standardization  is, in Rilke’s view, associated with 
large num bers and severe cost pressures: the  p o o r are “dying in  559 
beds” in  a dismally equipped  hospital funded  only by charity. But it is 
this association o f num bers and costs th a t invites us to  consider the 
relevance o f  Rilke’s concerns fo r contem porary  national health  care 
systems: afte r all, na tional health  systems involve bo th  very large 
num bers and very severe cost pressures. N or is there  any way to 
relieve e ith e r o f  these pressures: by definition, a national health  
system involves the largest possible num bers, since everyone is to be 
eligible for care; and, as in any health  system, a national health  system 
is continuously  subject to increasing cost pressures for which there  is 
no natu ra l solution. Since there  is always need for m ore rap id  and 
effective cure  o f disease, fo r b e tte r  ways o f contro lling  chronic 
conditions, fo r m ore reliable relief o f pain  w ith fewer side effects, and 
for m ore effective preventive efforts, and since there  are always m ore 
p atien ts who would benefit from  these developm ents, there  will 
always be cost pressures associated with providing b e tte r  health  care. 
F u rtherm ore , since all p a tien ts eventually die, there  is no natu ra l 
b ound  to the resources in  labor o r  technology which could be used to 
try  to ease o r  postpone this event.
E F F IC IE N C Y  IN  N A T IO N A L  H EA LTH  CARE
In  the  face o f very large num bers and con tinu ing  cost pressures, a 
national health  system will have, at least in princip le, a p red ictab le 
goal: the  developm ent o f g reater efficiency (also often  called cost-
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effectiveness4) in the trea tm en t and cure o f disease and  in  the  con tro l 
o f  chronic conditions. It will continuously  work to restru c tu re  its 
practices, including its medical practices, so as to achieve cure o r 
contro l fo r less money. The early sym ptom s o f this tendency are 
already apparen t, in the cu rren t transitional m edical clim ate, in the 
so-called “outcom es revo lu tion ” 5 evident in  some sectors o f U.S. 
m edicine and  followed w ith in terest by many E uropean  observers. 
This reo rien ta tio n  o f trea tm en t evaluation practices seeks to change 
m edicine’s conservative reliance on  conventional p a tte rn s o f p rac­
tice to d irec t inspection  o f the results ob ta ined  from  specific p roce­
dures, th a t is, it looks n o t so m uch at w hether the procedures 
physicians em ploy conform  to a standard  o f p ractice as at what 
results these procedures actually get. As outcom es are corre la ted  
w ith procedures, it is th en  possible to  form ulate efficient, cost- 
effective practice guidelines for the profession. For example, the 
federal Agency for H ealth  Care Policy and Research has already 
begun the developm ent o f practice guidelines for six com m on 
cond itions—angina pectoris, benign p rostatic  hypertrophy, gall­
stones, a rth ritis  o f the hip, conditions o f the u terus, and  low back 
pain—which now occasion trea tm en t am ounting  to  m ore th an  ha lf 
o f in p a tien t surgery .6 The effort here, at least in princip le , is to 
identify those procedures which are effective in trea tm en t, d iscard­
ing those which are not; to identify c rite ria  u n d e r which they should 
be perform ed; and  to stipulate  ways o f m easuring m orbidity  and 
m ortality  th a t will realistically reflect the effectiveness o f  the p roce­
d ure  given a specific severity o f illness—or, in  short, to identify the 
m ost effective way to  cure o r  con tro l these disease conditions, which 
can then  be co rre la ted  w ith cost considerations.
A sim ilar though  unnam ed  em phasis on  outcom es has long been 
at work in the developm ent o f associated practices such as preventa­
tive guidelines and  early diagnosis program s, including screening 
program s, prophylactic care, in struc tion  in self-help, genetic co un ­
seling, and so on. H ere, it is assum ed th a t prevention  o r early 
identification  o f a disease offers a m ore efficient way o f contro lling  o r  
cu ring  it th an  m edical in terven tion  could provide at a la te r p o in t in 
the expected course o f the disease. The im pulse behind  these p ro ­
gram s m ight be described as akin to the  concerns to be expected in a 
national health  program , inasm uch as the effort is to save money, as 
well as hum an  costs, fo r th e  popu la tion  as a whole. To be sure, some 
au thors have p o in ted  o u t th a t screening and  early-risk-identification  
program s can prove m ore expensive because they identify disease
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which then  requires trea tm en t b u t which would otherw ise go 
u n tre a te d ;7 partisan  b ickering th en  begins w hen it is observed that 
m oney to be expended  in prevention  program s in  a non-national 
system comes ou t o f d ifferen t pockets from  those th a t would realize 
the  savings. Nevertheless, in a well-designed national system, this 
need n o t be so ,8 and it rem ains the case th a t such program s are in 
general b o th  m ore hum ane and m ore efficient—if n o t initially 
ch eaper—ways o f respond ing  to disease.
Thus it appears th a t bo th  the  developm ent o f p ractice guidelines 
and  the developm ent o f prevention  and risk-identification  program s 
have in com m on th a t fea tu re  which Rilke suggests is the  roo t o f the 
problem  o f  dehum anization  in medicine: they invite “standardiza­
tion.” A fter all, p ractice  guidelines have the effect o f stipulating  to the 
physician how7 a given disease cond ition  is to be m anaged; prevention  
and  risk-identification  program s initially trea t all subjects uniformly, 
subjecting them  to the same screening procedures, and  then  feed 
those identified  as positive risks in to  the health  care system for 
trea tm en t u n d e r its practice  guidelines. B oth thus increase the 
likelihood th a t all pa tien ts w ith a given cond ition  will be trea ted  in a 
uniform , “standard ized” way. To be sure, sim ilar developm ents may 
also occur in m arket-based, n on-national health  care organizations; 
nevertheless, the  distinctive prob lem  of standardization  will be m ost 
acute in a national health  system for which efficiency in  care is the 
p rincipal objective.
O f course, to suggest th a t a national health  system would p red ic t­
ably m ake efficiency in cure o r  con tro l o f disease its cen tral objective 
is in certa in  ways an ideal view: it assumes th a t the  system’s adm inis­
tra to rs and  professionals, including physicians, are n o t function ing  
p rim arily  from  greed o r o th e r u lte rio r motives, th a t the system is well 
ru n  and  efficiently adm inistered , th a t the  developm ent o f bureauc­
racy w ithin  the  system is n o t so com plete as to take on  self-perpetuat­
ing characteristics, and th a t o th e r d istortions have n o t co rru p ted  the 
system. It overlooks the  bells and whistles a national health  system 
m ight have to add, perhaps at the  cost o f o th e r  efficient care, in  o rd e r 
to m ain tain  political su p p o rt .9 It also assumes th a t available funds are 
lim ited and  that, as we have seen, health  needs are never fully 
satisfied. B ut these conditions aside, a w ell-run national health  
system should nevertheless be m ore likely th an  a com m ercial health  
system to p rom ote  efficiency in providing health  care. Were it n o t the 
case th a t the  various factors involved are m uch too com plex to adm it 
such sim plistic com parisons, it would be tem pting  to p o in t o u t that
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the substantially b e tte r  health  status o f the popu lations o f  th e  m ajor 
industrialized nations with national health  care systems than  th a t o f 
U.S. citizens suggests ju s t such results: these populations, it would 
seem, get m ore efficient health  care: care th a t is as good o r b e tte r  
than  th a t in the U nited  States at substantially less cost.
W ell-run, com petitive, com m ercial health  care systems also seek 
to be efficient, o f course, b u t they seek to be efficient in  ways th a t 
enhance th e ir own profitability. For example, providers are likely to 
try  to increase th e ir  m arket share in providing a p articu la r service— 
w hether o r  n o t the  service is actually effective in cu ring  o r  co n tro l­
ling disease. Providers, at least those who are no t also payers, have less 
incentive to  seek effective care than  to expand the quan tity  o f care 
provided, especially when the p a tien t has little way o f determ in ing  
w hether the  care is necessary, since care is the source o f  th e ir  profit; 
this is the fam iliar p henom enon  o f overtreatm ent, a phenom enon  
directly  addressed by federal contro ls such as DRGs. O th e r strategies, 
such as offering am enities and advertising directly  to patients, 
represent additional techniques for stim ulating  dem and for services 
in a profit-m otivated system. In contrast, payers in a profit-m otivated  
system, unlike providers, seek to  lim it th e ir  obligations as a way o f 
enhancing  th e ir  profits; this strategy is cu rren tly  m ost evident in the 
insurance industry ’s a ttem p t to  move away from  com m unity  rating, 
in which all insurees w ithin  a geographic region are assum ed to pose 
the  same risk, to a refusal to cover specific individuals and  m em bers 
o f high-risk groups. B ut a national health  system, though both  
prov ider and payer, will pursue n e ith er o f these strategies; it canno t 
seek to increase m arket share by overtreatm ent, since there  are no 
com petito rs from  whom  to take away business; and it canno t seek to 
exclude high-risk individuals, since it is m andated  to cover everyone. 
It is therefo re  forced to seek efficiency in  providing the services it is 
requ ired  to give to all, since u n d e r lim ited fund ing  th e re  is no o th e r 
way fo r it to function .
Thus, the  essential features o f a national health  system, and  those 
features which encourage it to strive for “hea lth -ta rge ted” efficiency 
in providing care, are the m andate to provide care u n d e r a lim ited 
resource pool for very large num bers—everybody—and a lack o f 
com petito rs in  doing so. These features will be especially p ro ­
nounced  in  a w ell-run national p rovider system u n d e r which physi­
cians and  o th e r  providers are employees o f the state; b u t they will also 
characterize a national insurance system in  which reim bursem ent 
schedules are tigh t and explicit enough  to  con tro l physician and
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o th e r p rov ider autonom y by lim iting  options for practice. In  e ither 
form  o f national system, if physician and  o th e r  prov ider activity is 
contro lled  by practice  guidelines which have been  developed on  the 
basis o f d em onstra ted  effectiveness in achieving specific outcom es, 
and if, fu rtherm ore , the  system is m andated  to  provide care for all, 
there  will be no in te rna l incentive to provide m ore care in general o r 
m ore care for som e people th an  is needed. W hile there  will still be 
pressures to exclude some types o f trea tm en t, there  can be no 
pressures to exclude individuals o r high-risk groups. In  general, 
n e ith e r overtrea tm ent n o r risk-exclusion will be favored. To be sure, 
we already notice some o f these a ltered  trends in o u r cu rren t 
transitional system: quelling overtreatm ent is already a goal in  some 
com ponents o f U.S. health  care, including  federal and state program s 
like M edicaid and  M edicare, the VA, and large health  m ain tenance 
organizations which, opera tin g  alm ost like m in i-national health  
systems, are th e ir  own payers as well as providers. Resisting exclusion 
is also becom ing a goal, at least in some states—for instance, in  those 
a ttem p tin g  to  expand M edicaid coverage o r  to develop insurance 
pools fo r persons deem ed uninsurab le  by com m ercial firms.
E F F IC IE N C Y  A N D  “ BEST B U Y S ”
If  health -targeted  efficiency is predictably  to be the cen tral goal in a 
national health  system, as d istinct from  the pro fit-targeted  efficiency 
to  be expected in com petitive com m ercial systems, it is essential to 
explore what form s health -targeted  efficiency m ight take and  to 
consider w hether these form s o f efficiency would give rise to  the kind 
o f standardization  and  consequent dehum anization  against which 
Rilke warns. In  the  absence o f co rru p tin g  features, we can expect a 
national health  system to be a system in which cost pressures opera te  
to  influence th e  form ulation  o f  practice  guidelines, and  in  which the 
least expensive way o f  achieving the  best outcom es will be designated 
as the  standard  regulating  all m edical care. Leaving aside for the 
m om ent the scientific and research difficulties o f m easuring o u t­
com es and  developing practice  guidelines, as well as the  adm inistra­
tive difficulties o f p ro m o tin g  universal use o f them , one way a 
national health  system’s tendency to  favor health -targeted  efficiency 
m ight take shape is in  selecting n o t the  best way to cure o r  contro l 
disease b u t th e  m ost efficient, cost-effective way to do so. A national 
health  system opera tin g  u n d e r substantial cost pressures m ight thus 
em ploy—to use the  te rm  Consumer Reports m ade fam ous—n o t the  best
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procedures for cu ring  illness, b u t the  “best buy” in  p rocedures for 
doing  so. Examples o f best buys in procedures, as d istinguished from  
the best p rocedures for trea ting  the same conditions, include a 
n um b er o f m odalities which are m arkedly cheaper th an  th e ir  “best” 
co un te rp arts  bu t still give nearly as good results. These m ight 
include, for example, the  use o f hydrochlorothiazide instead  o f ace 
inh ib ito rs fo r hypertension; the use o f m edical ra th e r th an  surgical 
m ethods o f trea tin g  appendicitis; the use o f trad itional ra th e r  than  
low-osmolality contrast m edium s in radiologic imaging; the  use o f 
cheaper, nonp rescrip tio n  niacin instead o f  the  p rescrip tio n  d rug  
cholestyram ine in contro lling  serum  cholesterol; the  use o f  m edical 
ra th e r  than  surgical m ethods o f  trea ting  coronary  h e a rt disease; 
reliance on n o n rep a ir ra th e r  than  reconstruction  in a c l - m c l  liga­
m ent knee injuries; m edical ra th e r  th an  surgical m ethods o f  trea ting  
ulcers; and the  use o f asp irin  in place o f  nonsteroidal an tiin flam m a­
tory drugs o r n s a i d s . Perhaps the m ost visible controversy over best 
versus best-buy options has been th a t involving the  throm bolytic 
agents t p a  and strep tok inase for use following m yocardial infarction  
(m i ): despite the results o f the m ajor Gissi-2 and Isis-3 studies 
concluding th a t the two drugs are o f equal efficacy in  saving the  lives 
o f heart-a ttack  patients, some physicians con tinue to  insist tha t 
a lthough streptokinase, at as little as $76 a dose, may be a best buy, the 
$2 ,2 0 0 -per-dose t p a  is nevertheless best.
Traditionally, considerations o f the effectiveness o f a p rocedure  
have in p rincip le  been given g rea ter weight in the U nited  States than  
considerations o f  cost: this is why the U nited  States has developed a 
m edical system providing care that, while very, very good, is also very, 
very expensive: its m edical system has been providing first-class care, 
at least for some people, and has not, u n til recently, w orried  m uch 
abou t the price. It has insisted on  the  best, n o t on  best buys. The 
p rospect o f a national health  system seeking full efficiency in provid­
ing care for all b u t opera ting  u n d e r budget lim itations, however, 
forces us to consider w hether it ought to tu rn  to best buys in 
m edicine ra th e r  than  the trad itional best in o rd e r to m ake ends 
meet.
To be sure, what counts as a best buy is a func tion  o f  the am ount 
o f resources available, following the  intuitive n o tio n  th a t a best buy is 
the best item  o f its k ind one can get fo r the m oney one has available. If 
resources are n o t very lim ited the  best buy will be nearly as good as 
the best; u n d e r g reater scarcity, however, the  difference between 
them  will be p ronounced . In  e ith e r case, a national health  system
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relying o n  fully dem onstra ted  cost-effective best-buy practice  guide­
lines o r standards o f p ractice for all m edical and  associated services 
would provide, in theory  at least, the  m ost benefits fo r the least cost 
fo r all persons. This would provide an alternative way o f p u ttin g  into 
p ractice  the no tio n  o f “decent m in im um ”: access to  all services fo r all 
persons, b u t services o f lesser efficacy.
Developing p ractice  guidelines o r  standards o f practice  based 
e ith e r o n  best o r  on  best-buy trea tm en ts is itself a form  of s tand ard ­
ization: such guidelines a ttem p t to  describe and  p u t in to  practice  a 
un ifo rm  way o f providing care for each disease condition , thus 
producing  results for each p a tien t which are uniform ly effective to 
the same degree. In  general, by codifying and  regularizing uniform  
ways o f trea tin g  specific conditions, well-developed practice  guide­
lines benefit all pa tien ts with such conditions except the  few statisti­
cal ou tliers—th a t is, pa tien ts who would have responded  b e tte r  to 
some less o rthodox  form  of treatm ent. But a carefully developed 
practice guideline will have few if any such patien ts and, m ore 
im portan t, it will be im possible to p red ic t which individuals they are; 
fo r if it were possible to p red ic t which pa tien ts would respond  b e tte r 
to  some o th e r  form  o f trea tm ent, this fact would call fo r the develop­
m en t o f a new practice  guideline fo r this specific subgroup. Thus, 
practice guidelines are, in  p rincip le, maximally effective. O f course, 
in real life, u n d e r any system, practice  guidelines in some contentious 
areas o f m edicine are likely to be adop ted  n o t ju s t on  the basis o f 
unequivocal, exhaustive repo rtin g  o f clinical experience and  im pec­
cable scientific research b u t on  the  basis o f political pressures from  
various groups partia l on  less-than-scientific grounds to one form  of 
trea tm en t o r  another. T hen  too, the  developm ent o f practice  guide­
lines p resen ts o th e r  p roblem s—m ost notably, the problem s o f how 
such guidelines can be challenged, if accepted  practice  is uniform  
an d  there  is no way sho rt o f form al, contro lled  trials to gather 
con trary  findings; w hether the disincentives for challenging guide­
lines would stifle clinical progress in m edicine; w hether they would 
provide too easy a target for litigation; as well as the problem  
m en tioned  earlie r o f ensuring  universal com pliance .10 F urtherm ore , 
there  are continu ing  problem s abou t m easuring the efficacy o f 
trea tm en t, abou t weighing the value o f  various objectives (e.g., pain  
contro l versus rehabilitation), and  about weighing nonm edical fac­
tors such as the value o f privacy o r  confidentiality. Yet these problem s 
do n o t outw eigh the overwhelm ing utility  o f efficient p ractice guide­
lines in a cost-pressured system. In contrast to a m arket system in
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which some patien ts get precisely the trea tm en t they need  b u t o th e r 
patien ts are und ertrea ted , overtreated, trea ted  inappropriately, o r  
no t trea ted  at all, depend ing  on what incentives affect the  physicians 
who provide th e ir  care, a system based on p ractice guidelines— 
unifo rm  th rou g h ou t the  m edical system, and universally observed— 
would provide the  m ost efficient care for all patients.
But, o f course, the developm ent o f “best-buy” practice  guidelines 
u n d e r cost constrain ts involves standardization  at a lower level o f 
effectiveness th an  when “best” guidelines are used. Discussion o f 
d isparate  levels o f care in m edicine is already fam iliar talk in  p ro ­
posals for tw o-tiered health  care systems, b u t the  conjecture here 
abou t what a national health  program  would favor is d ifferent. It 
considers an alternative form  o f tw o-tiered national health  system, 
one which relies for cost savings n e ith e r on  excluding individuals 
from  trea tm en t (as would be p roh ib ited  in a national health  system in 
any case) n o r on  excluding certa in  conditions o r procedures, such as 
transp lan ts (a form  o f tie ring  which invites political pressure from  
advocacy groups for pa tien ts with specific diseases), b u t which 
instead establishes two (or perhaps m ore) sets o f  practice  guidelines 
to be em ployed depend ing  on w hether the  p a tien t is receiving 
publicly funded  o r  privately paid  care. O f course, tw o-tiered systems 
provide little p ro tec tion  against erosion o f the lower tier; if overall 
fund ing  for a public system is meager, the  gap betw een highest- 
quality-possible care and  m ost-efficient-given-the-budget-lim ita- 
tions care (that is, between best and best-buy care) could  be quite 
large indeed, even though all persons would be eligible for care. 
Nevertheless, this form  o f a tw o-tiered system, u n d e r which best-buy 
care would be provided for the  publicly funded  and  best care for 
those who could cover the  additional cost, is dem onstrably  m ore ju s t 
than  o th e r form s o f public/private tiering  (if any tiered  system can be 
said to be just), since it im poses the liabilities o f less adequate, lower- 
tie r care equally on all publicly funded  persons ra th e r than, as in  an 
exclusion system, on  some few individuals from  th a t group.
R IL K E ’S PA R A D O X ? BEST A N D  B E ST -B U Y  SYSTEM S
Is it possible th a t a gap o f this so rt is the real prob lem  which Rilke’s 
concerns with standardization  would have us address, though  o f 
course there  were no practice  guidelines in tu rn-o f-the-century  
France? The H otel-D ieu, com m itted  to providing for all the poo r 
with lim ited charitable  resources, would no d oub t have had to
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practice a crude k ind  o f  cost-efficiency, o f which standardization  o f 
practice would have been  an earm ark. Perhaps it is this standardiza­
tion  th a t Rilke observes: “They are dying in 559 beds,” he writes, 
“factory-like, o f course.” H e continues this ironic industria l m eta­
phor: “W here p ro d u c tio n  is so enorm ous an  individual death  is no t 
so nicely carried  out; b u t th en  th a t doesn’t m atter. It is quantity  that 
counts.” O f course, Rilke m ight be objecting  simply to  the medicaliza- 
tion  o f  death  generally o r to a k ind o f crude reg im entation  in 
m edicine th a t pays little  real a tten tio n  to outcom es o r  the results o f 
hea lth  care—th a t is, to  e ith e r socially o r  m edically callous w arehous­
ing o f  the  dying—b u t his argum ent is still m ore in teresting  if we 
assum e th a t the  H otel-D ieu is doing the best it can to trea t its 
p a tien ts’ illnesses and th a t the standardization  Rilke is objecting  to 
involves practices as efficient as possible given the m edical science o f 
the  tim e. W hether o r n o t this is what Rilke saw, it is w hat Rilke lets us 
see.
Yet w hat we see is paradox. If we look closely at Rilke’s concerns, 
we see th a t the issue o f  standardization  in  m edical care is m uch m ore 
com plex th an  we m ight at first expect, and  th a t even his images o f 
illness an d  poverty do n o t su p p o rt any general rejection  o f s tand ard ­
ization  o r  the a p p a ren t claim  th a t it dehum anizes people. Consider, 
fo r instance, his image for the depersonalized  cond ition  o f the poor: 
if he were n o t p oo r he would ren t an o th er room , he says, and 
describes the effort it has cost h im  to lean his head  on the  a rm chair in 
the  roo m  he curren tly  occupies. The a rm chair has a greasy-gray 
hollow in to  which all heads seem to fit—the heads o f the previous, 
equally p o o r and  transito ry  occupants o f this shabby room . N ot all of 
these occupan ts have been  o f the  same physical size, b u t they have all 
been obliged to accom m odate themselves to the same green a rm ­
chair a n d  it is the fact th a t persons are forced by circum stances to 
accom m odate themselves to a standardized item  n e ith e r chosen by 
them  n o r  suited to  them  that is the  basis o f Rilke’s com plaint. But is it 
a co m pla in t th a t would also apply to an efficient national health  
system based on  best-buy standards o f practice, even one stre tched  by 
an inadequately  funded  a ttem p t to provide health  care for all to the 
p o in t w here its “decent m inim um ,” as stipulated  by its lower-tier 
standards, is set qu ite  low? To be sure, com plaints abou t standardiza­
tion, uniform ity , and regim entation  are a staple o f naive objection  to 
social-welfare systems generally; b u t Rilke’s objection  is m uch m ore 
subtle in  its com m ent on  the  special n a tu re  o f health  care.
A fte r  all, Rilke’s argu m en t against s tand ard iza tio n  initially
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appears a ltogether inadequate  in the  health  care context. Indeed, it 
does no t even work for the fu rn itu re  o f room ing houses. However 
d isp iriting  a th ing  it may be, an item  o f  fu rn itu re  like the  green 
a rm chair in his room  is rem arkably efficient. Given cost pressures so 
severe th a t an arm chair appropriately  adapted  to each new occupan t 
canno t be provided, this unappealing  green chair m anages to  accom ­
m odate everyone: “all heads seem  to fit.” It would o f course be 
p referable for each individual to live in a b e tte r-eq u ip ped  room  with 
fu rn itu re  o f his o r  h e r own; b u t for the poor, it is this shabby room  o r 
now here at all. A nd it is this chair, used by all the  previous dow n-and- 
o u t tenants, o r  no  chair at all. Given no possibility o f expanding  the 
pool o f resources available in  this situation, the  green arm chair 
actually serves its purpose  rem arkably well: “all heads seem  to fit.”
Analogously, in health  care, it is p referable to receive “standard ­
ized” low er-tier health  care, including trea tm en t stipulated  in stand ­
ards o f p ractice and  in mass prevention  and iden tification  program s, 
th an  to receive no care at all. B etter to fit one’s head  in to  the  greasy- 
gray hollow in the green arm chair than  to sit on the floor. O f course, 
one m ight idealistically sp u rn  the arm chair, p re ferring  to cam p on 
the  floor, b u t the  analogy does n o t work in m edicine: unless one 
rejects health  care a ltogether o r some com ponents o f it for ex trane­
ous reasons (for example, on  religious grounds, on  the basis o f fears 
abou t specific p rocedures, o r on  the basis o f  differing values about 
risk) o r  because the risk o f iatrogenic com plication  is high, some 
health  care is b e tte r  th an  none at all. A fter all, the  consequence o f no 
trea tm en t may be dysfunction, pain, o r  death, and  it is never ra tional 
to p refer these to probable  cure o r  resto ra tion  o f  function , except 
perhaps on  outside grounds.
Thus, in  a cost-pressured national health  system, one may imag­
ine a tw o-tiered system with dual practice  guidelines. In  such a 
system, for example, appendicitis pa tien ts in the  lower tier, who 
would be trea ted  m edically ra th e r  than  surgically, m ight have a 
slightly g rea ter chance o f dying than  those in the  u p p e r  tier, bu t 
nobody would risk the substantially g rea ter chance o f  dying that 
exclusion from  trea tm en t a ltogether would entail. Patients in the 
lower tie r would use n iacin  ra th e r  than  cholestyram ine, b u t they 
would still be getting  m edical supervision o f th e ir  cholesterol levels. 
Knee pa tien ts in  the lower tie r could expect conservative trea tm en t 
o f th e ir  a c l - m c l  injuries, and  while this would leave them  unable to 
play certa in  sports and risk some instability, they could still function  
fairly well in m ost activities. Patients getting  m edical ra th e r  than
surgical trea tm en t o f th e ir  ulcers would do nearly as well; and  in all 
these circum stances, no  p a tien t would risk being entirely  excluded 
from  trea tm ent. A lthough patien ts undergoing  radiologic contrast 
studies would get trad itio n al ra th e r  than  low-osmolality contrast 
m edium s and  would therefo re  be at g reater risk o f anaphylactic 
reactions, no p a tien t would be denied  necessary diagnostic p ro ce­
dures. A nd w hether o r  n o t t p a  m ight eventually prove to have some 
therapeu tic  advantage over streptokinase, low er-tier pa tien ts would 
get streptokinase, while u p p e r-tie r  p atien ts (or th e ir  physicians) 
m ight be p e rm itted  a choice; yet all h ea rt attack  patien ts would 
receive effective throm bolytic therapy .11 O f course, a tw o-tiered 
system risks allowing a substantial gap to develop betw een the u p p e r 
and  the  lower tiers; on  the o th e r  hand, if, as in C anada, the system 
p ro h ib ited  a second tie r (as I believe ju stice  ultim ately  requires), 
political pressures would opera te  to keep the  level o f the  single tie r  as 
high as possible. In  e ith e r case, however, incentives characterizing a 
system u n d e r cost pressures, w ithout com petition , m andating  care 
for all, would—if it were a system attentive enough  to the requ ire ­
m ents o f  ju stice  to reject exclusion practices th a t im pose unequal 
liabilities on  persons—encourage the developm ent o f p ractice  stand ­
ards for m aximally efficient health -targeted  care. Thus, w hether a 
n ational health  system is a single-tiered o r  tw o-tiered one (or p e r­
haps has m ultip le  tiers), standardization  is n o t the disadvantage a 
cursory reading  o f Rilke o r inspection  o f  o u r own stereotypes m ight 
seem to  suggest b u t is, on  the contrary, the  m echanism  o f its p rincipal 
advantage. O f course, “standardization” does n o t m ean u tte r  u n i­
form ity  in every detail o f m edical practice, and  it does no t require  
rou tin ized  in teractions, inflexible schedules, physicians with indis­
tinguishable smiles and  identical bedside m anners, o r  exam ining 
room s all p a in ted  the same color. It refers only to ad op tio n  o f the 
m ost effective p ractice  w here differences in practice make dem on­
strable differences in outcom e, and  it requires only the  d iscarding o f 
dem onstrably  ineffective, less effective, o r  dam aging ways o f doing 
things. Variety can flourish, b u t n o t uselessness o r harm fulness, and 
because uselessness and  harm fulness do n o t flourish, such a system 
provides the  m ost effective care fo r all. T ied to considerations o f cost, 
such a system would provide the  m ost efficient care u n d e r cost- 
lim iting  constrain ts. This, I have argued, would m ost likely be the 
case, b a rrin g  o th e r  co rrup tions, in  a national health  system th a t is 
noncom petitive b u t cost p ressured  and m andated  to  provide care for 
all.
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B ut it would be hasty to conclude that Rilke’s in tu itions are 
simply w rong and th a t there  is no m oral p roblem  raised by the 
p rospect o f standard ization—even by the p rospect o f the  so rt o f 
thoroughgoing standardization  one m ight expect from  a genuinely 
efficient national health  system. Rilke describes dying at the H otel- 
Dieu as “factory-like,” a situation  w here “p ro d u ctio n  is enorm ous” 
and it is “quantity  th a t counts.” B ut if it is “factory-like” th a t all items 
o f a k ind are trea ted  in the  same way, and if “p ro d u c tio n  is enorm ous” 
m eans th a t everyone gets what he o r  she needs, th en  there  is no m oral 
p rob lem  here. Q uan tity  does count: th a t is the  whole p o in t o f national 
health  systems, to ensure th a t everyone gets the  health  care he o r  she 
needs.
Yet there  is som ething else to notice abou t Rilke’s observations: 
they are focused on a specific kind o f health  care, and  the p o in t he has 
to make has special application  in this setting. W hat the  pa tien ts in 
the  559 beds o f the H otel-D ieu are doing is dying-, this is a hospital for 
incurables, fo r term inal cases, as d istinct from  the  M aison d ’Ac­
couchem ent, the obstetric  hospital, and the Val-de-Grace, the  m ili­
tary hospital, down the street. The division o f these hospitals in 
Rilke’s tu rn-o f-the-cen tury  Paris reflects a d istinction  cen tral in his 
observations: there  is som ething different abou t dying, and  it is in 
dying as d istinct from  o th e r m edical events th a t the  m oral problem s 
raised by standardization  arise. It is no t ju s t th a t Rilke is obsessed 
w ith the n o tion  o f d ea th —as n o t only Rilke b u t the Existentialists 
influenced by h im  would also be—b u t that he sees that there  is 
som eth ing  d ifferen t from  o th e r  m edical situations ab o u t this 
process.
E F F IC IE N C Y  IN  D Y IN G
W hat, then, is d isturb ing  about the “factory-like p ro d u ctio n ” o f 
deaths in the 559 beds o f the  Hotel-Dieu? No one cares anym ore for a 
“finely-finished death,” Rilke lam ents. “No one. Even the rich, who 
could after all afford this luxury o f dying in full detail, are beginning 
to  be careless and indifferent; the wish to have a death  o f one’s own is 
growing ever ra re r .” 12 But if o u r account o f efficiency in m edical care 
is correct, surely the “factory-like p roduction” o f deaths would not 
raise any m oral problem , unless o f course it wrere accom panied by 
callousness, abuse, o r  cruelty—periphera l in stitu tional problem s 
which are n o t p a rt o f o u r focus here.
But this brings us to the cen tral problem : the very no tions o f
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“standards o f practice” and “practice guidelines” canno t function  in 
the same way in dying as they do for the trea tm en t o f o th e r m edical 
conditions, because these are concepts th a t make cen tral reference 
to the m edical outcom e to be attained. T he p rocedure  o r  m edical 
trea tm en t to be designated as standard  in a practice guideline fo r a 
given cond ition  is the  one which is m ost effective in p roducing  cure 
o r con tro l o f the  cond ition  w ithin the  lim its o f resources available: it 
is the  m ost efficient, cost-effective m an ner o f p roducing  a given 
outcom e. B ut the  sense in which death  is the “outcom e” o f m edical 
trea tm en t is a very d ifferent one from  the one associated with 
m easurem ents o f efficacy in standards o f practice, as, for instance, 
cure o f appendicitis is the outcom e of appendectom y o r con tro l of 
kidney failure is the  outcom e o f  dialysis. Unlike cure o r  the contro l o f 
a chronic condition , death  is no t the  objective o f m edical trea tm en t 
and n o t the  outcom e in term s o f which efficacy can be m easured. 
Medical trea tm en t does no t aim  at death; m edical trea tm en t aims at 
cure o r the contro l o f a condition , and  death  occurs only if it fails 
ra th e r  than  succeeds. Thus, there  can be no such th ing  as an 
“efficient” o r “cost-effective” way o f dying, since, except in the 
specific final p rocedure  o f  euthanasia, death  canno t be the objective 
o f  trea tm en t. Even in the hospice care provided to term inally ill 
patien ts, death  is n o t the objective, a lthough it is the expected, 
unresisted  outcom e; on  the contrary, the  objective, to use the rh e to ­
ric associated with this im p o rtan t m ovem ent, is the fullest, best 
possible living o f the last m om ents o f life. If  death  were the objective, 
e ith e r in o rd inary  m edical care o r  in hospice care, efficient dying 
would be th a t which gets the process over w ith in  the  shortest and 
hence cheapest possible tim e—b u t this is what few patien ts o r 
physicians would regard  as ideal and what no national health  o r 
sim ilar system ought to encourage. This is n o t to encourage the 
p ro longation  o f life, b u t it is no t to encourage arbitrarily  ab ru p t 
te rm ination  o f life either. Cheap, rap id  dying may be a personal goal 
for some p atien ts b u t ought no t be im posed as an in stitu tional o r 
societal one.
But if there  can be no such th ing  as “efficient dying,” there can be 
no standards o f practice  for dying either, even w hen the dying is 
expected to follow the  usual p a tte rn  o f a pred ictab le  downhill course 
in a fam iliar fatal disease—advanced colon cancer, for instance, o r 
kidney failure o r lung disease. At best, one could string  together a 
series o f procedures, each governed by its own practice guidelines, 
fo r the events o r  m edical episodes along the  way o f this downhill
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course—for example, a p rocedure  to relieve tu m o r pressure on a 
nerve, therapy for congestive h eart failure, trea tm en t to relieve 
resp iratory  distress—but this is to view dying as a series o f isolated, 
d iscrete events and to miss, as it were, the  forest for the trees. If dying 
is seen as an integral process, no t ju s t as a series o f in terconnected  
m edical failures, u nderstand ing  it in the term s ap p ro p ria te  to o th e r 
areas o f m edicine canno t fully succeed. T here is no best buy in dying, 
though  there  may be best buys in specific sorts o f sym ptom  relief; 
there  is no standard, efficient p a tte rn  th a t dying ought to follow. This 
is n o t to rom anticize dying b u t only to rem ark  th a t viewing it in the 
way ap p ro p ria te  to o th e r  m edical conditions is to cu t off from  view 
w hat we m ost ought to see: it is a circum stance in which efficiency is 
beside the  point.
It m ight be suggested that Rilke’s overwhelm ing concern  with 
d eath  raises only a tangential issue in m edicine. But this is hardly so, 
especially given the  cost-re la ted  issues th a t fuel p ressures for 
n ational health  care. A fter all, according to the various figures so 
frequently  cited in discussions o f health  care’s high cost, an im m ense 
p ro p o rtio n  o f health  care dollars are spen t in  the  last m onth, two 
m onths, o r half-year o f life. O f course, the last m onth, two m onths, o r 
half-year o f life can be identified only retrospectively, and  n o t all 
pa tien ts were “dying” du rin g  those periods. Nevertheless, in  a society 
in  which approxim ately th ree  o f every fou r deaths occur as a result of 
degenerative disease (cancer, h ea rt disease, stroke, liver, kidney and 
o th e r organ failure, a i d s , neurological diseases, etc.) and  deaths from  
acute, rapidly fatal parasitic and infectious diseases and  trau m a are 
com paratively few, the issue o f how dying is to take place in a cost- 
pressured, efficiency-oriented system, as a ju s t national health  system 
m ust be, is no  trivial m a tte r and  canno t rem ain  o f p eriph era l in terest 
only.
In Rilke’s view, m ost systems—n o t only th a t o f  charity  care for the 
p o o r o f Paris at the  H otel-D ieu b u t also E urope’s private sanato ria  for 
the  wealthy—do function  in effect by im posing standardized  p rac­
tices even in term inal cases. “O ne dies the death  th a t belongs to the 
disease one has,” Rilke rem arks, “for since one has com e to  know all 
diseases, one knows, too, tha t the d ifferen t lethal term inations 
belong to the diseases and  no t to the people; and  the sick person  has 
so to speak n o th ing  to do.” This is what I’ve called the no tio n  o f  the 
“official” death, and  it is what one m ight expect were standards o f 
practice form ulated  to govern the whole scope o f th a t series o f 
m edical events characteristic  o f specific downhill, term inal courses.
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It is this standard ization  in dying th a t Rilke sees as particularly  
dehum anizing; he writes, sarcastically, “In sanatoria, w'here people 
die so willingly and with so m uch g ra titude  to doctors and nurses, 
they die from  one o f the deaths a ttached  to the institu tion ; th a t is 
favorably regarded .” 14
O f course, one m ight argue th a t the  objective o f m edical care in 
dying is th e  achievem ent o f the  longest life possible consistent with 
the least suffering; thus, there  is a “standard  o f practice” in the 
b ro ad e r sense even for dying. Indeed, this seems to be the assum ption 
o f  con tem porary  term inal care: there  is a course deem ed to be the 
easiest, which the p a tien t can be expected and  encouraged to follow. 
But Rilke—and here it is difficult and im p o rtan t to be sensitive to his 
in tu itio n —would regard  this as an im position  o f values where, 
because there  is no objective goal for m edical care, there  is no 
legitim ate basis for doing so. W hile some dying p atien ts m ight regard 
a term inal period  weighing m axim ized life against m inim ized pain  as 
preferable, o thers m ight p refer it some o th e r  way. As an illustration, 
Rilke creates the  ex traord inary  ch aracter C ham berlain  C hristoph  
Detlev Brigge, whose death  was “two m onths long and  so loud th a t it 
could  be heard  as far off as the m anor farm .” 15 To be sure, Rilke 
rom anticizes a vigorous, rebellious, alm ost a th letic  dying—a value 
ju d g m en t there  is no  need for us to  accep t—b u t what he thus 
succeeds in po in ting  ou t is tha t there  is no reason at all why everyone 
should die in  the  same way. Such contem porary  devices as Living 
Wills may seem  to p ro tec t individual choice, b u t they are n o t very 
robust: in general, advance directives m ean only th a t one’s course 
th rough  the  standard  progression o f dying can be in te rru p ted  after 
one is no  longer com peten t, typically quite late in the  game. The wish 
to have “a death  o f one’s own” ough t to be recognized, indeed 
adm ired, Rilke insists, and in this he is clearly right, since because it is 
no t like o th e r  m edical processes there  is no com pelling reason for it 
to be any one, un ifo rm  way. Indeed, diversity may be the best 
p ro tec tion  against m an ipu la tion  and abuse. It is precisely the having 
o f “a death  o f one’s own,” however, th a t the standardization  o f 
practice, clearly so efficient and beneficial in o th e r areas o f m edicine, 
would preclude. Being trea ted  for appendicitis o r  hypertension  o r 
ulcers o r a c l - m c l  knee injuries o r  m yocardial in farction  “factory­
like” in 559 beds (assum ing the  personal character o f the  care 
provided is hum ane, not literally factory-like, and  the  institu tional 
env ironm ent reasonably pleasant) would p resen t no m oral problem , 
because trea tin g  these conditions in the m ost efficient way would
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increase all 559 pa tien ts’ chances o f cure, especially w here no 
patien ts risk non trea tm en t. But dying is different, and  it is no t 
morally ap p ro p ria te  for a system governed by princip les o f efficiency 
to im pose a standard  expectation  o f how this final period  o f  an 
ind ividual’s life should play itself out. Perhaps it is ap p ro p ria te  for a 
society to reassess its com m unal expectations abou t the  n a tu re  o f old 
age and  m edical responses to dying, as D aniel Callahan would 
recom m end ,16 b u t it is n o t the  role o f a single, so le-provider system in 
effect to decide o r enforce this.
A national health  care system may certainly be greeted  with 
enthusiasm  on  many grounds (and I strongly su p p o rt its ad op tio n  in 
the  U nited  States), b u t—especially w here very large p ro p o rtion s o f 
its resources are at stake— it may also pose substantial m oral p ro b ­
lems. I th ink  these risks are greatest in  m atters o f dying. O f course, 
com petitive, for-p ro fit health  care systems also pose m oral risks 
concern ing  dying, though  these risks will differ as a function  o f the 
d ifferen t incentives u n d e r which these various systems operate . A 
p articu la r risk in com petitive, free-m arket systems is a fun c tio n  o f 
incentives to increase the quan tity  and technical quality o f care 
perform ed: this may take the form  o f leng then ing  the  process o f 
dying so as to be able to  provide m ore care, a p ractice which has been 
the focus o f  m uch public sen tim en t against the “pro longation” o f 
dying. I th ink  the risks in  dying we can expect to see posed u n d e r a 
national hea lth  care system will be less dam aging to  individual 
welfare than  those we are now subject to in o u r  c u rren t health  care 
environm ent, even in the m ore com plex real world th an  the  idealized 
version considered  here, b u t th a t does n o t m ean we can p re ten d  
there  are none. N or is it the case th a t the eth ical issues a national 
health  care system will generate, for all its advantages, will be lim ited 
to the  m a tte r o f dying, b u t they will be particularly  conspicuous in 
this difficult area.
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